![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 39/085 | (2006.01) |
(11) | Number of the document | 2566507 |
(13) | Kind of document | T |
(96) | European patent application number | 11724567.0 |
Date of filing the European patent application | 2011-05-04 | |
(97) | Date of publication of the European application | 2013-03-13 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
(46) | Date of publication of the claims translation | 2018-02-12 |
(86) | Number | PCT/EP2011/057111 |
Date | 2011-05-04 |
(87) | Number | WO 2011/138361 |
Date | 2011-11-10 |
(30) | Number | Date | Country code |
332170 P | 2010-05-06 | US |
(72) |
WACKER, Michael, CH
KOWARIK, Michael, CH
WETTER, Michael, CH
|
(73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Kapsulinės gram-teigiamos bakterijos biokonjugato vakcinos |
CAPSULAR GRAM-POSITIVE BACTERIA BIOCONJUGATE VACCINES |
Payment date | Validity (years) | Amount | |
2023-04-20 | 13 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-05-04 |